Safety and Efficacy Study of the Draeger Babylog VN500 Device in HFOV Mode in VLBW Neonates

NAUnknownINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

May 8, 2018

Study Completion Date

September 30, 2020

Conditions
Respiratory Distress Syndrome In Premature Infants
Interventions
DEVICE

Babylog VN500 in HFOV Mode

Treatment with high frequency oscillatory ventilation with investigational device for up to 14 days

Trial Locations (14)

28402

New Hanover Regional Medical Center, Wilmington

29425

Medical University of South Carolina, Charleston

39216

University of Mississippi Medical Center, Jackson

52242

University of Iowa Hospitals and Clinics, Iowa City

55102

St. Paul Children's Hospital, Saint Paul

55404

Children's Hospitals and Clinics of Minnesota, Minneapolis

72202

Arkansas Children's Hospital, Little Rock

University of Arkansas for Medical Sciences, Little Rock

78258

North Central Baptist Hospital, San Antonio

84107

Intermountain Medical Center, Murray

92123

Sharp Mary Birch Hospital for Women and Newborns, San Diego

02905

Women & Infants Hospital of Rhode Island, Providence

78229-3900

University of Texas Health Science Center at San Antonio, San Antonio

84158-1289

University of Utah Health Science Center, Salt Lake City

Sponsors
All Listed Sponsors
lead

Draeger Medical Systems, Inc.

INDUSTRY

NCT02445040 - Safety and Efficacy Study of the Draeger Babylog VN500 Device in HFOV Mode in VLBW Neonates | Biotech Hunter | Biotech Hunter